C

CorMedix
D

CRMD

11.230
USD
-0.50
(-4.22%)
مغلق
حجم التداول
36,105
الربح لكل سهم
1
العائد الربحي
-
P/E
45
حجم السوق
835,839,534
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 9 أشهر
buy
2024-10-03 08:52
CRMD Chart
المزيد
أصول ذات صلة
A
AGEN
1.15500
(19.53%)
7.07000 USD
A
AKBA
-0.04500
(-1.13%)
3.92500 USD
C
CLRB
-0.17000
(-3.39%)
4.85000 USD
D
DVAX
-0.310
(-2.85%)
10.580 USD
M
MDGL
1.35
(0.43%)
315.88 USD
R
RDHL
0.06000
(2.82%)
2.19000 USD
R
RMTI
-0.16000
(-12.50%)
1.12000 USD
S
SNDX
-0.22000
(-2.24%)
9.61000 USD
المزيد
الأخبار المقالات

العنوان: CorMedix

القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.